In arms A , B , and C , rates of early treatment discontinuation were 6.3 % , 4.9 % , and 8.9 % ; of discontinuation due to an AE , 2 % , 3 % , and 3 % ; and of AEs requiring dose modification , 3 % , 6 % , and 10 % , respectively .